US 2014/0179784 A1Published application

Levothyroxine formulation with carrageenan

AssigneeMylan Inc.

InventorsJohn Kirsch, Ramakrishna Nallamothu, Baris E. Polat

Life of this patent

Estimating the term…

Abstract

A pharmaceutical composition comprising thyroxine and carrageenan. The pharmaceutical composition has an improved shelf life compared to other pharmaceutical compositions containing thyroxine. In one embodiment, the composition additionally comprises sucrose, microcrystalline cellulose, and mannitol. The pharmaceutical composition may be used for treating thyroid disorders by orally administering the composition to a patient in need thereof.

Claims20

Dependent claims

A pharmaceutical composition comprising thyroxine and carrageenan.

Dependencies are inferred from the claim text.

Facts

Application: 13/723,500Filed 21 Dec 2012
Published: 26 Jun 2014
Term ends: Not estimatedThe source records don’t support an estimate.

Classification6 codes

A61K 47/36
Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates: polysaccharides; Derivatives thereof, e.g. gums, starch, alginate,…
A61K 9/2018
Organic compounds, e.g. phospholipids, fats: sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
A61K 9/205
Organic macromolecular compounds: polysaccharides, e.g. alginate, gums; Cyclodextrin
A61K 31/198
The amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine,…:…

Family

No related US applications are recorded in the indexed filing history.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results